Skip to main content
Top
Published in: Breast Cancer Research 2/2008

01-05-2008 | Poster presentation

An exploration of the management of menopausal symptoms for women with a diagnosis of breast cancer: lay and professional experiences and expectations

Authors: S Cruickshank, A Hume, EM Alder

Published in: Breast Cancer Research | Special Issue 2/2008

Login to get access

Excerpt

Many breast cancer survivors are menopausal either at diagnosis or as a result of a premature therapy-induced menopause, complaining frequently of climacteric symptoms [1]. The menopause is widely seen as part of the natural ageing process; however, for many women who have had treatment for breast cancer; it can be viewed as a further complication, which can significantly impact on their quality of life as they recover from cancer treatment [2]. The increased symptoms often coincide with a time of transition from the completion of intensive treatment to follow-up care when there can be a perceived decrease in levels of support [3]. The limited evidence to guide practice both pharmacologically and nonpharmacologically within breast cancer has created a confused environment, for both clinicians and patients [4]. The aim of the present study was therefore to explore the experiences and expectations of both women with breast cancer and the health professionals, in relation to the management of menopausal symptoms in a clinical setting. …
Literature
1.
go back to reference Biglia N, Cozzarello M, Ponzone R, Roagna R, Maggiorotto F, Sismondi P: Menopause after breast cancer: a survey of breast cancer survivors. Maturitas. 2003, 45: 29-38. 10.1016/S0378-5122(03)00087-2.CrossRefPubMed Biglia N, Cozzarello M, Ponzone R, Roagna R, Maggiorotto F, Sismondi P: Menopause after breast cancer: a survey of breast cancer survivors. Maturitas. 2003, 45: 29-38. 10.1016/S0378-5122(03)00087-2.CrossRefPubMed
2.
go back to reference Schultz P, Klein MJ, Beck ML, Stava C, Sellin R: Breast cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors. J Clin Nurs. 2005, 14: 204-211. 10.1111/j.1365-2702.2004.01030.x.CrossRefPubMed Schultz P, Klein MJ, Beck ML, Stava C, Sellin R: Breast cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors. J Clin Nurs. 2005, 14: 204-211. 10.1111/j.1365-2702.2004.01030.x.CrossRefPubMed
3.
go back to reference Ganz PA, Greendale GA, Peterson L, Zibecchi L, Kahn B, Belin TR: Managing menopausal symptoms in breast cancer survivors: results of a randomised controlled trial. J Natl Cancer Inst. 2000, 92: 1054-1064. 10.1093/jnci/92.13.1054.CrossRefPubMed Ganz PA, Greendale GA, Peterson L, Zibecchi L, Kahn B, Belin TR: Managing menopausal symptoms in breast cancer survivors: results of a randomised controlled trial. J Natl Cancer Inst. 2000, 92: 1054-1064. 10.1093/jnci/92.13.1054.CrossRefPubMed
4.
go back to reference Farrell E: Medical choices available for the management of menopause. Best Pract Res Clin Endocrinol Metab. 2003, 17: 1-16. 10.1016/S1521-690X(02)00087-8.CrossRefPubMed Farrell E: Medical choices available for the management of menopause. Best Pract Res Clin Endocrinol Metab. 2003, 17: 1-16. 10.1016/S1521-690X(02)00087-8.CrossRefPubMed
Metadata
Title
An exploration of the management of menopausal symptoms for women with a diagnosis of breast cancer: lay and professional experiences and expectations
Authors
S Cruickshank
A Hume
EM Alder
Publication date
01-05-2008
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2008
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1966

Other articles of this Special Issue 2/2008

Breast Cancer Research 2/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine